These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8105253)

  • 1. Eosinophilia after intradermal hepatitis B vaccination.
    Nagafuchi S; Tokiyama K; Kashiwagi S; Yayashi S; Imayama S; Niho Y
    Lancet; 1993 Oct; 342(8877):998. PubMed ID: 8105253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Localized scleroderma after hepatitis B vaccination].
    Schmutz JL; Posth M; Granel F; Trechot P; Barbaud A
    Presse Med; 2000 May 27-Jun 3; 29(19):1046. PubMed ID: 10874914
    [No Abstract]   [Full Text] [Related]  

  • 3. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced necrobiotic granuloma.
    Ajithkumar K; Anand U; Pulimood S; Chandi SM; George S; Jacob CK; Thomas PP
    Clin Exp Dermatol; 1998 Sep; 23(5):222-4. PubMed ID: 10233605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against hepatitis B: comparison of intradermal and intramuscular administration of plasma derived and recombinant vaccines.
    Payton CD; Scarisbrick DA; Sikotra S; Flower AJ
    Epidemiol Infect; 1993 Feb; 110(1):177-80. PubMed ID: 8432320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual loss and eosinophilia after recombinant hepatitis B vaccine.
    Brézin A; Lautier-Frau M; Hamedani M; Rogeaux O; Hoang PL
    Lancet; 1993 Aug; 342(8870):563-4. PubMed ID: 8102709
    [No Abstract]   [Full Text] [Related]  

  • 12. Intradermal vaccination for hepatitis B.
    Woodruff BA; Moyer LA
    Clin Infect Dis; 1992 Dec; 15(6):1063-6. PubMed ID: 1296645
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of hepatitis B vaccine regimens in adults with HIV-1.
    Bélec L; Authier FJ; Gherardi RK
    JAMA; 2011 Jul; 306(2):156; author reply 156-7. PubMed ID: 21750288
    [No Abstract]   [Full Text] [Related]  

  • 14. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
    Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
    Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
    Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
    Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal hepatitis B vaccination: a systematic review and meta-analysis.
    Sangaré L; Manhart L; Zehrung D; Wang CC
    Vaccine; 2009 Mar; 27(12):1777-86. PubMed ID: 19200451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular versus intradermal hepatitis B vaccination.
    Milne A
    N Z Med J; 1986 Aug; 99(808):640. PubMed ID: 2944039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.